Goldman Sachs lowered its forecast for the total market for anti-obesity drugs through the end of the decade. Asad Haider, ...

Some consumers take tiny doses of Ozempic and other GLP-1 drugs or stretch out doses to cut costs and side effects.

While the market reels from President Trump’s “Liberation Day” tariffs, legendary investor Louis Navellier says something ...